Siemens Healthineers AG
XETRA:SHL
Relative Value
The Relative Value of one
SHL
stock under the Base Case scenario is
54.31
EUR.
Compared to the current market price of 40.24 EUR,
Siemens Healthineers AG
is
Undervalued by 26%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SHL Competitors Multiples
Siemens Healthineers AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.3B EUR | 1.9 | 21.3 | 11.8 | 16.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.1B USD | 4.4 | 29.9 | 17 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.7B USD | 17.5 | 61.7 | 46.9 | 57.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
137B USD | 5.5 | 42.6 | 21.6 | 26.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
127.5B USD | 3.7 | 26.9 | 15.1 | 21.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108.4B USD | 5.5 | 38 | 22.6 | 30.4 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.6B USD | 12 | 48.7 | 34.8 | 38.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.4B USD | 2.4 | 30.8 | 11.6 | 19.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.6B USD | 7.8 | 33.4 | 23.7 | 26 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37.8B USD | 7 | 25.3 | 17.9 | 19.9 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
35.8B USD | 1.8 | 16.2 | 12.1 | 14.7 |